New research examines the long-term use of medication for irritable bowel syndrome and points to potential risks associated ...

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

Too often, people promote remedies for irritable bowel syndrome that have little to no scientific backing.

Some Irritable bowel syndrome (IBS) medications show an association with increased long-term risk The overall risk for individual patients remains small, but it is important to consider Personalized ...

April is IBS Awareness Month. Learn about irritable bowel syndrome symptoms, diagnosis, and treatment options.

A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments.

A large new study links common IBS drugs like loperamide and diphenoxylate to a higher risk of death. Experts say the risk is ...

Two dietary interventions were more effective in reducing irritable bowel syndrome (IBS) symptom severity compared with pharmacotherapy, a randomized controlled trial showed. After 4 weeks of ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.

From abdominal pain and bloating to urgent bathroom trips and constipation, irritable bowel syndrome (IBS) can be a disruptive condition to live with. Fortunately, there are treatments available that ...

Amitriptyline can significantly improve symptoms of irritable bowel syndrome (IBS), according to a study led by the universities of Leeds, Southampton, and Bristol. The researchers urged that the ...

Dietary treatment is more effective than medications in irritable bowel syndrome (IBS). These are the findings of a study conducted at the University of Gothenburg. With dietary adjustments, more than ...